Immune effector cell hybrids

Details for Australian Patent Application No. 2003271378 (hide)

Owner Genzyme Corporation Dana-Farber Cancer Institute, Inc.

Inventors Kufe, Donald; Nicolette, Charles; Roberts, Bruce; Gong, Jianlin

Agent Davies Collison Cave

Pub. Number AU-B-2003271378

Parent 23392

Filing date 24 December 2003

Wipo publication date 29 January 2004

Acceptance publication date 25 January 2007

International Classifications

A61K 35/00 (2006.01) Medicinal preparations containing material or reaction products thereof with undetermined constitution

C12N 15/85 (2006.01) Mutation or genetic engineering - for animal cells

C12Q 1/68 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - involving nucleic acids

G01N 33/53 (2006.01) Investigating or analysing materials by specific methods not covered by groups - Immunoassay

Event Publications

22 January 2004 Complete Application Filed

29 January 2004 Application Open to Public Inspection

  Published as AU-B-2003271378

25 January 2007 Application Accepted

  Published as AU-B-2003271378

24 May 2007 Standard Patent Sealed

9 October 2008 Offer to Surrender

  Genzyme Corporation One Mountain Road PO Box 9322 , DanaFramingham Massachusetts 01701-9322; Farber Cancer Institute, Inc. 44 Binney Street , Boston MA 02115, the Patentee of Letters Patent 2003271378 dated 11.05.2007 for an invention titled ' Immune effector cell hybrids' offers to surrender the said Letters Patent. Any person desiring to be heard before the said offer to surrender is accepted must lodge a request to be heard within one month from the date of this journal.

27 November 2008 Innovation Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003271379-Activation and protection of T-cells (CD4+ and CD8+) using H2 receptor agonist and other T-cell activating agents

2003271377-Cosmetic eye implant, use of such implant, method for providing such implant and eyes provided therewith